| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.08 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |